NEW YORK, May 09, 2017 -- Fiduciary Trust Company International, a global investment manager and wholly-owned subsidiary of Franklin Templeton Investments, today announced its opening of an office in Arlington, Virginia. Located at 3033 Wilson Boulevard, the new office is overseen by Bill Leffingwell, regional managing director and head of Fiduciary Trust’s Washington, D.C. office.
“This new Arlington office is the perfect complement to our established regional Washington, D.C. and Delaware offices,” said John M. Dowd, chief executive officer of Fiduciary Trust. “Expanding our presence in Virginia allows us to better serve our clients by providing them with direct, personal access to the depth and breadth of our investment and trust management services. We look forward to building on our presence in this region and becoming part of the vibrant Virginia wealth management community.”
“We are excited to strengthen our ties in this region and demonstrate our long-term commitment to our clients, as well as the trust and estate, tax, and legal communities," said Mr. Leffingwell.
About Fiduciary Trust
Fiduciary Trust Company International, a global investment management firm, has served individuals, families, endowments and foundations since 1931. With over $78 billion in assets under administration and management as of March 31, 2017, the firm specializes in strategic wealth planning, investment management and trust and estate services, as well as tax and custody services. The firm and its subsidiaries maintain offices in New York, Coral Gables, FL, Boca Raton, FL, St. Petersburg, FL, Los Angeles, San Mateo, CA, Washington, D.C., Wilmington, DE, Arlington, VA, and London. For more information, please visit fiduciarytrust.com.
About Franklin Resources
Franklin Resources, Inc. (NYSE:BEN) is a global investment management organization operating as Franklin Templeton Investments. Franklin Templeton Investments provides global and domestic investment management to retail, institutional and sovereign wealth clients in over 170 countries. Through specialized teams, the company has expertise across all asset classes -- including equity, fixed income, alternative and custom solutions. The company's more than 650 investment professionals are supported by its integrated, worldwide team of risk management professionals and global trading desk network. With offices in over 30 countries, the California-based company has 70 years of investment experience and approximately $741 billion in assets under management as of April 30, 2017. For more information, please visit franklintempleton.com.
Copyright © 2017. Fiduciary Trust Company International. All rights reserved.
Contacts: Rebecca Radosevich: 212-632-3207 [email protected] Michael Chiong: 646-922-7764 [email protected]


TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Instagram Outage Disrupts Thousands of U.S. Users
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 



